Pacific Biosciences
PACB
PACB
99 hedge funds and large institutions have $331M invested in Pacific Biosciences in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 10 closing their positions.
Holders
99
Holders Change
-2
Holders Change %
-1.98%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
38
Reduced
26
Closed
10
Calls
$182K
Puts
$495K
Net Calls
-$313K
Net Calls Change
+$39K
Top Buyers
1 |
AIM
1
ARK Investment Management
St. Petersburg,
Florida
|
$22.4M |
2 |
BC
2
Broadfin Capital
New York
|
$3.74M |
3 |
3
BlackRock
New York
|
$34.2M |
4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$10.3M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$21.1M |